Table 1.
Location | Number of mutations | Codon | Mutation | Region(s) of strain(s) |
---|---|---|---|---|
Matrix protein | 2 | 1 | ||
209 | Asp → His | Singapore | ||
3′UTR | 3 | N/A | ||
Intergenic region | 5 | N/A | ||
Intergenic region | 6 | N/A | ||
Nucleocapsid protein | 7 | 4 | ||
148 | Thr → Ile | China (Shenzhen) | ||
194 | Ile → Leu | China (Shenzhen) China (Foshan) USA USA | ||
202 | Ser → Asn | Australia | ||
344 | Pro → Ser | Hong Kong (Guangzhou) | ||
5′ UTR | 8 | N/A | ||
Spike polyprotein | 14 | 8 | ||
32 | Phe → Ile | China (Wuhan) | ||
49 | His → Tyr | China (Guangdong) | ||
247 | Ser → Arg | Australia | ||
354 | Asn → Asp | China (Shenzhen) | ||
364 | Asp → Tyr | China (Shenzhen) | ||
367 | Val → Phe | France | ||
614 | Asp → Gly | Germany | ||
1143 | Pro → Leu | Australia | ||
ORF1ab polyprotein | 48 | 29 | ||
117 | Ala → Thr | USA | ||
309 | Pro → Ser | France | ||
428 | Ser → Asn | USA | ||
609 | Thr → Ile | USA | ||
1176 | Ala → Val | Japan | ||
1599 | Leu → Phe | Korea | ||
1607 | Ile → Val | USA | ||
2194 | Met → Thr | China (Shenzhen) | ||
2235 | Leu → Ile | China (Wuhan) | ||
2244 | Ile → Thr | China (Wuhan) | ||
2251 | Gly → Ser | China (Wuhan) | ||
2345 | Ala → Val | China (Shandong) | ||
2534 | Gly → Val | China (Wuhan) | ||
2579 | Asp → Ala | China (Wuhan) | ||
2708 | Asn → Ser | China (Wuhan) | ||
2908 | Phe → Ile | China (Wuhan) | ||
3058 | Thr → Ile | France | ||
3099 | Ser → Leu | China (Shenzhen) | ||
3606 | Leu → Phe | China (Yunnan) China (Shandong) China (Chongqing) Singapore France USA | ||
3764 | Glu → Asp | Japan | ||
3833 | Asn → Lys | China (Wuhan) | ||
5308 | Trp → Cys | Taiwan | ||
5579 | Thr → Ile | USA | ||
6075 | Ile → Thr | England | ||
6083 | Pro → Leu | Japan | ||
6309 | Phe → Tyr | China (Sichuan) | ||
6565 | Glu → Asp | China (Shenzhen) | ||
6958 | Lys → Arg | China (Wuhan) | ||
7018 | Asp → Asn | China (Wuhan) |